Increase in constitutively active MEK1 species by introduction of MEK1 mutations identified in cancers

Emiko Kinoshita-Kikuta1, Eiji Kinoshita1, Sayaka Ueda1

  • 1Department of Functional Molecular Science, Graduate School of Biomedical & Health Sciences, Hiroshima University, Kasumi 1-2-3, Minami-ku, Hiroshima 734-8553, Japan.

Insights

Mutations in the MEK1 gene can enhance its activity, leading to cancer. Phos-tag analysis reveals how these mutations cause resistance to MEK inhibitors, offering insights for targeted cancer therapy.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Mitogen-activated protein kinase (MAPK) cascades are crucial cellular signaling pathways.
  • The kinase MEK1 is a key component of these cascades, and its dysregulation through somatic mutations is implicated in various cancers.
  • Aberrant MEK1 activity makes it a significant therapeutic target for cancer treatment.

Purpose of the Study:

  • To investigate the functional consequences of MEK1 mutations found in sporadic cancers and drug-resistant cell lines.
  • To characterize the phosphorylation status and activity of MEK1 mutants using Phos-tag affinity electrophoresis.
  • To assess the impact of these mutations on MEK1 inhibitor resistance.

Main Methods:

  • Utilized Phos-tag affinity electrophoresis to analyze the phosphorylation status of MEK1.
  • Introduced specific MEK1 mutations associated with cancer and drug resistance.
  • Performed phosphorylation profiling of MEK1 mutants in the presence of RAF/MEK inhibitors.

Main Results:

  • Mutations in MEK1 led to constitutively active forms of the kinase, characterized by phosphorylation at Ser-218 and Ser-222 residues.
  • Several MEK1 mutations conferred resistance to multiple MEK inhibitors.
  • This resistance was associated with an increased abundance of active, phosphorylated MEK1 species.

Conclusions:

  • Phos-tag-based phosphorylation profiling is a valuable tool for understanding MEK1 mutation characteristics.
  • The findings provide clinical insights into MEK1-driven cancers and mechanisms of inhibitor resistance.
  • This approach can aid in the development of more effective targeted cancer therapies.

Related Concept Videos

Mutations01:39

Mutations

Overview
94.6K
What is a Species?01:17

What is a Species?

Overview
50.5K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.0K
Keystone Species01:39

Keystone Species

Measures of species biodiversity, such as richness (i.e., the number of species present) and evenness (i.e., their relative abundance), describe an ecological community’s structure. Many factors affect community structure, including abiotic factors (e.g., sunlight and nutrients), disturbances (e.g., fire or flood), species interactions (e.g., predation or competition), and chance events (e.g., foreign species invasion). Certain species—such as keystone species—also play a...
25.0K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
40.0K
Constitutional Isomers of Alkanes02:18

Constitutional Isomers of Alkanes

Organic compounds of the same molecular formula can have different structural formulas called constitutional isomers, and the phenomenon is known as constitutional isomerism. Alkanes with four or more carbons showing multiple structures with the same molecular formula thereby exhibit constitutional isomerism.
The linear isomer of an alkane is prefixed by the term “n”; hence a linear isomer of pentane is known as n-pentane. Based on the type of branching, some of the...
22.8K